Status:

COMPLETED

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

Lead Sponsor:

Beacon Therapeutics

Conditions:

X-Linked Retinitis Pigmentosa

Eligibility:

MALE

6+ years

Brief Summary

The purpose of this study is to evaluate subjects with X-linked retinitis pigmentosa caused by RPGR-ORF15 mutations in a clinical setting to fully characterize their condition, measure testing variabi...

Detailed Description

Males with a clinical diagnosis of X-linked retinitis pigmentosa (XLRP) caused by RPGR-ORF15 mutations will be asked to provide informed consent and will have a single blood or saliva sample obtained ...

Eligibility Criteria

Inclusion

  • Male subjects with a clinical diagnosis of XLRP and a documented molecular diagnosis from a CLIA-certified laboratory of mutation within the ORF15 exon of the RPGR gene;
  • At least 6 years of age;
  • Willing and able to perform study procedures;
  • Signed informed consent(s) obtained (and child assent where applicable).

Exclusion

  • Pre-existing eye conditions that would interfere with interpretation of study endpoints (e.g. glaucoma, corneal or lenticular opacities, diabetic retinopathy, history of retinal detachment);
  • Participating in an interventional research study of drugs or devices for treatment of XLRP or other retinal diseases;
  • Monoocular participants
  • Any condition which leads the investigator to believe that the participant cannot comply with the protocol requirements or that may place the participant at an unacceptable risk for participation.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 10 2022

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT03314207

Start Date

December 1 2017

End Date

February 10 2022

Last Update

January 11 2023

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Duke Eye Center, Duke University Medical Center

Durham, North Carolina, United States, 27710

2

Casey Eye Institute, Oregon Health and Sciences University

Portland, Oregon, United States, 97239

3

Retina Foundation of the Southwest

Dallas, Texas, United States, 75231

Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP) | DecenTrialz